Weight is over! Pharma companies race to make weight-loss drug semaglutide

Indian drugmakers, including Dr. Reddy's and Zydus Lifesciences, are investing heavily in manufacturing capabilities to launch generic versions of Novo Nordisk's Wegovy and Ozempic as patents expire. These companies are developing novel technologies and aligning capacities for delivery pens, targeting both the Indian market and exports.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3su46ET
via IFTTT